Epitomee Medical Ltd (TLV:EPIT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 779.20
-27.30 (-3.39%)
Mar 9, 2026, 5:24 PM IDT
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 242.65 million as of March 9, 2026. Its market cap has decreased by -18.14% in one year.
Market Cap
242.65M
Enterprise Value
196.20M
Revenue
n/a
Ranking
n/a
PE Ratio
218.14
Stock Price
779.20
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 242.65M, a decrease of -79.87%. That is a compound annual growth rate of -31.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 242.65M | 33.16% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 114.36B |
| Danel (Adir Yeoshua) | 2.83B |
| Kamada | 1.62B |
| BrainsWay | 1.58B |
| Bonus BioGroup | 512.72M |
| Geffen Residence & Renewal | 277.04M |
| Golden House | 166.80M |
| Matricelf | 146.87M |